Supplementarty Materials: Real-world safety of Spesolimab: A pharmacovigilance analysis using the FDA Adverse Event Reporting System
Published: 1 November 2026| Version 1 | DOI: 10.17632/3mf7t2jjns.1
Contributors:
, , , , Junguo duanDescription
Supplementarty Materials: Real-world safety of Spesolimab: A pharmacovigilance analysis using the FDA Adverse Event Reporting System
Files
Institutions
- Chengdu University of Traditional Chinese MedicineSichuan, Chengdu
Categories
Psoriasis, Drug Safety, Pharmacovigilance, Disproportionality Analysis